BlueCrest Capital Management »

Mineralys Therapeutics shares owned by BlueCrest Capital Management

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by BlueCrest Capital Management from 13F filings

Historical chart of BlueCrest Capital Management investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by BlueCrest Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by BlueCrest Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.3M 85k 26.98

More positions owned by BlueCrest Capital Management

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Spdr Series Trust St Str P500etf (SPYM)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Vaneck Etf Trust Semiconductr Etf (SMH)
Amazon (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Micron Technology (MU)
Echostar Corp Cl A
Taiwan Semiconductor Manufac Sponsored Ads Put Option (TSM)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf Put Option (BKLN)
Zoom Communications Cl A (ZM)
Jazz Investments I Note 3.125% 9/1 (Principal)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Criteo S A Spons Ads (CRTO)

View all positions for BlueCrest Capital Management

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
BlackRock
Samsara BioCapital
FMR
Deerfield Management Company
State Street Corporation
Armistice Capital
Vanguard Capital Management
Laurion Capital Management
OrbiMed Advisors
Troluce Capital Advisors
Franklin Resources
Andera Partners
Geode Capital Management

View all funds holding Mineralys Therapeutics